Clinical and economic outcomes assessment with myocardial contrast echocardiography

Heart

Volumn 82, Issue SUPPL. 3, 1999, Pages

  Shaw, Leslee J ^a,d   Monaghan, Mark J ^b   Nihoyannopoulos, Petros ^c  

^a EMORY UNIVERSITY   (United States)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST ECHOCARDIOGRAPHY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; HEALTH CARE COST; HEART CATHETERIZATION; HEART DISEASE; PRIORITY JOURNAL; REVIEW; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADRENERGIC BETA-AGONISTS; COST SAVINGS; COST-BENEFIT ANALYSIS; DOBUTAMINE; ECHOCARDIOGRAPHY; HEART DISEASES; HUMANS;

EID: 0344631583     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Hsiah A, Jollis JG, Kesler KL. Prognostic value of transthoracic echo in the Duke cardiovascular disease database [abstract]. Circulation 1996;94:1-27.
2. Kaul S. Myocardial contrast echocardiography: 15 years of research and development. Circulation 1997;96:3745-60.
3. Feinstein SB, Becher II, Macioch JE, et al. Rush-Prcsbytcrian-St Luke's clinical use of contrast echocardiography. A continuing education atlas. Philadelphia; American Journal of Cardiology, 1998:1-48.
4. Kaul S. Myocardial contrast echocardiography. Curr Probl Cardiol 1997;22:549-635.
5. Cohen JL, Cheirif J, Segar DS, et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III multicenter trial, J Am Coll Cardiol 1998;32:746-52.
6. Ikonomidis I, Holmes E, Narbuvold H, et al. Assessment of left ventricular wall morion and delineation of the endocardial border after intravenous injection of Infoson during dobutamine stress echocardiography. Coron Artery Dis 1998;9:567-76.
7. Marwick TH, Brunken R, Meland N, et al. Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography. The Nycomed NC100100 investigators. J Am Coll Cardiol 1998;32:1260-9.
8. Fuster V, Epidemic of cardiovascular disease and stroke. Circulation 1999;99:1132-7.
9. Levit KR, Lazensby HC, Braden BR, National health expenditures. Health Aff (Millwood) 1996;17:35-51.
10. Burner ST, Waldo DR, McKusick DR. National health care expenditures. Health Care Financing Review 1996;14:1-30.
11. http://www.amhrt.org/stats/1997.
12. Ginzberg E. Health services research. Cambridge, MA: Harvard University Press, 1991.
13. Fuchs U. The future of health policy. Cambridge, MA: Harvard University Press, 1993.
14. Drummond MF, Jefferson TO. Guidelines tor authors and peer reviewers of economic submissions to the BMJ. The BMJ economic evaluation working party. BMJ 1996;313:275-83.
15. Finkler S. Cost accounting for health care organizations: concepts and applications. Gaithersburg, MD: Aspen Publishers, 1994.
16. Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilisation? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992;146:473-81.
17. Weinstein MC, Stason WK, Cost-effectiveness of coronary artery bypass surgery. Circulation 1982;66:III56-66.
18. Mark D. Medical economics and health policy issues for interventional cardiology. 2nd ed. Textbook of interventional cardiology, Philadelphia, PA; WB Saunders, 1993.
19. Weintraub WS, Mauldin PD, Becker E, et al. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory angioplasty versus surgery trial (EAST). Circulation 1995;92:2831-40.
20. Goldman L, Garber AM, Grover SA, et al. 27th Bethesda conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task force 6, Cost effectiveness of assessment and management of risk factors. J Am Coll Cardiol 1996;27:1020-30.
21. Shaw LJ, Eisenstein EL, Hachamovitch R, et al. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: part II. J Nucl Cardiol 1097;4:52-60.
22. Shaw L, Hachamovitch R, Berman D, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. J Am Coll Cardiol 1999;33:661-9.
23. Marwick TH, Anderson T, Williams MJ, et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995;26:335-41.
24. Shaw LJ, Dittrich HC, West H, et al. Cost effectiveness of myocardial contrast echocardiography as compared to nuclear perfusion imaging in the diagnosis of coronary disease. 9th annual scientific sessions of the American Society of Echocardiography, San Francisco, CA, June 10-13, 1998 [abstract]. J Am Soc Echocardiogr 1998;11:512.
25. Shaw L, Hachamovitch R, Eisenstein E, et al. Cost implications for implementing a selective preoperative risk screening approach for peripheral vascular surgery patients. American Journal of Managed Care 1997;3:1817-27.
26. Rubin DN, Ballal RS, Marwick TH. Outcomes and cost implications of a clinical-based algorithm to guide the discriminate use of stress imaging before noncardiac surgery. Am Heart J 1997;134;83-92.
27. Redberg RF. Diagnostic testing for coronary artery disease in women and gender differences in referral for revascularization. Cardiol Clin 1998;16:67-77.
28. Shaw LJ Gillam L, Feinstein S, et al. Technology assessment in the managed care era: use of an intravenous contrast agent (FS069-Optison) to enhance cardiac diagnostic testing. Am J Managed Care 1998;4:SP169-76.
29. Underwood SR, Godman B, Salyani S, et al. Economics of myocardial perfusion imaging in Europe - the EMPIRE study. Eur Heart J 1999;20:157 66.
30. Sakuma T, Hayashi Y, Sumii K, et al. Prediction of short-and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography on day after recanalization. J Am Coll Cardiol 1998;32:890-7.
31. Meza MF, Ramee S, Collins T, et al. Knowledge of perfusion and contractile reserve improves the predictive value of recovery of regional myocardial function post-revascularization: a study using the combination of myocardial contrast echocardiography and dobutamine echocardiography. Circulation 1997;96:3459-65.
32. Vernon S, Kaul S, Powers ER, et al. Myocardial viability in patients with chronic coronary artery disease and previous myocardial infarction: comparison of myocardial contrast echocardiography and myocardial perfusion scintigraphy. Am Heart J 1997;134:835-40.
33. Agati L, Voci P, Autore C, et al. Combined use of dobutamine echocardiography and myocardial contrast echocardiography in predicting regional dysfunction recovery after coronary revascularization in patients with recent myocardial infarction. Eur Heart J 1997;18:771-9.
34. Spencer KT, Bednarz J, Rafter PG, et al. Use of harmonic imaging without echocardiographic contrast to improve two-dimensional image quality. Am J Cardiol 1998;82:794-9.
35. Crouse LJ, Cheirif J, Hanly DE, et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the phase III Albunex multicenter trial. J Am Coll Cardiol 1993;22:1494-500.
36. Kelsey A, Shaw L, Ryan T. Fifteen years of exercise echocardiography; a meta-analysis. 70th scientific sessions of the American Heart Association, Orlando, FL [abstract]. Circulation 1997;96:I-276.
37. Fleischmann KE, Hunink MG, Kuntz KM, et al. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998;280:913-20.
38. Shaw L, Hachamovitch R, Marwick T, et al. Cost effectiveness analysis of stress myocardial perfusion imaging in stable angina patients: influence of age and pretest risk of coronary disease. 46th annual scientific sessions for the American College of Cardiology 1997, Anaheim, CA [abstract]. J Am Coll Cardiol 1997;29:137A.
39. Shaw LJ, Ryan T, Cohen JL, et al. Estimation of myocardial perfusion with Optison contrast cchocardiography. 71st annual scientific sessions of the American Heart Association, Dallas, TX [abstract]. Circulation 1998;17:I-214.
40. Poldemans D, Fioretti PM, Boersma E, et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease. Circulation 1999;97:1474-80.
41. Chuah SC, Pellikka PA, Roger VL, et al. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 1998;97:1474-80.
42. McCully RB, Roger VL, Mahoney DW, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1325 patients. J Am Coll Cardiol 1998;31:144-9.